Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11873495
Compounds and methods for reducing LRRK2 expression
granted -
US 11859180
Antisense oligonucleotide compositions
granted -
US 11851655
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 11840686
Modulation of prekallikrein (PKK) expression
granted -
US 11840689
Method of treating fatty liver disease
granted -
US 11833221
Oligomeric compounds for reducing DMPK expression
granted -
US 11834660
Compositions for modulating Ataxin 2 expression
granted -
US 11833168
Compounds and methods for increasing STMN2 expression
granted -
US 11786546
Compounds and methods for modulating GFAP
granted -
US 11781143
Modulators of PNPLA3 expression
granted -
US 11761000
Compositions and their uses directed to huntingtin
granted -
US 11753644
Compounds and methods for reducing IFNAR1 expression
granted -
US 11732265
Compositions and methods for modulating complement factor B expression
granted -
US 11725208
Conjugated antisense compounds and their use
granted -
US 11713462
Modulation of GYS1 expression
granted -
US 11634711
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 11633483
Modulators of PCSK9 expression
granted -
US 11629348
Linkage modified oligomeric compounds and uses thereof
granted -
US 11613752
Compositions and methods for modulating PKK expression
granted -
US 11583548
Compounds and methods for reducing ATXN3 expression
granted -
US 11547718
Modulators of FOXP3 expression
granted -
US 11542504
Compounds and methods for modulating ATXN1
granted -
US 11535849
Modulation of transthyretin expression
granted -
US 11530411
Methods for reducing LRRK2 expression
granted